GB1476624A - Tranquiliser medicaments - Google Patents

Tranquiliser medicaments

Info

Publication number
GB1476624A
GB1476624A GB2575073A GB2575073A GB1476624A GB 1476624 A GB1476624 A GB 1476624A GB 2575073 A GB2575073 A GB 2575073A GB 2575073 A GB2575073 A GB 2575073A GB 1476624 A GB1476624 A GB 1476624A
Authority
GB
United Kingdom
Prior art keywords
tranquiliser
medicaments
antioxidant
ester
methyl arachidonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2575073A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CEPBEPE
Original Assignee
CEPBEPE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CEPBEPE filed Critical CEPBEPE
Priority to GB2575073A priority Critical patent/GB1476624A/en
Publication of GB1476624A publication Critical patent/GB1476624A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • C07C57/12Straight chain carboxylic acids containing eighteen carbon atoms

Abstract

1476624 Antianxiety preparations CENTRE D'ETUDES EXPERIMENTALES ET CLINIQUES DE PHYSIO-BIOLOGIE DE PHARMACOLOGIE ET D'EUTONOLOGIE 24 May 1974 [30 May 1973] 25750/73 Heading A5B A medicament for combatting excitation and anxiety comprises (a) arachidonic acid or an ester thereof and (b) an antioxidant. The antioxidant may be vitamin E or glutathione. The preferred ester is methyl arachidonate. In Example methyl arachidonate is separately mixed with amphetomine and aspirin.
GB2575073A 1973-05-30 1973-05-30 Tranquiliser medicaments Expired GB1476624A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2575073A GB1476624A (en) 1973-05-30 1973-05-30 Tranquiliser medicaments

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2575073A GB1476624A (en) 1973-05-30 1973-05-30 Tranquiliser medicaments
FR7417692A FR2231379B1 (en) 1973-05-30 1974-05-21
DE19742425988 DE2425988A1 (en) 1973-05-30 1974-05-30 anxiety syndromes drug used to control excitation and

Publications (1)

Publication Number Publication Date
GB1476624A true GB1476624A (en) 1977-06-16

Family

ID=10232682

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2575073A Expired GB1476624A (en) 1973-05-30 1973-05-30 Tranquiliser medicaments

Country Status (3)

Country Link
DE (1) DE2425988A1 (en)
FR (1) FR2231379B1 (en)
GB (1) GB1476624A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831507A1 (en) * 1978-05-26 1979-11-29 Wellcome Found (All-Z) -5,8,11,14,17-eicosapentaenoic acid and / or derivatives thereof containing formulations, as well as processes for their preparation
EP0087865A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical composition
AU663923B2 (en) * 1992-04-08 1995-10-26 Transcend Therapeutics, Inc Method and composition for treating immune disorders, inflammation and chronic infections
WO2005107875A2 (en) * 2004-05-12 2005-11-17 Ketocytonyx Inc. Triglycerides, fatty acids, alcohols as cns modulators
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205076A (en) * 1982-08-09 1985-04-30 Univ California Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid
EP0106571A3 (en) * 1982-09-22 1984-07-25 Sentrachem Limited Prophylactic substance or composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R Prolonged and continuous dermal pharmaceutical compositions based on essential fatty acids
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
FR2573653B1 (en) * 1984-11-23 1988-02-26 Pf Medicament Antiandrogen pharmaceutical compositions based on fatty acids
FR2581310B1 (en) * 1985-05-02 1988-09-23 Natura Medica Laboratoires Therapeutic composition comprising a-linolenic acid and a compound capable of promoting acid through the cell membrane and plant extract comprising the acid and the compound
DE3615710A1 (en) * 1986-05-09 1987-11-26 Hoechst Ag Preparations for the synthesis of prostaglandines and hydroxy fatty acids in biological systems
DE3719097C1 (en) * 1987-06-06 1988-06-09 Fratzer Uwe Medicament containing eicosapentaenoic acid and docosahexaenoic acid as unsaturated fatty acids as well as vitamin E.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831507A1 (en) * 1978-05-26 1979-11-29 Wellcome Found (All-Z) -5,8,11,14,17-eicosapentaenoic acid and / or derivatives thereof containing formulations, as well as processes for their preparation
EP0087865A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical composition
EP0087865B1 (en) * 1982-03-01 1986-10-01 Efamol Limited Pharmaceutical composition
AU663923B2 (en) * 1992-04-08 1995-10-26 Transcend Therapeutics, Inc Method and composition for treating immune disorders, inflammation and chronic infections
WO2005107875A2 (en) * 2004-05-12 2005-11-17 Ketocytonyx Inc. Triglycerides, fatty acids, alcohols as cns modulators
WO2005107875A3 (en) * 2004-05-12 2006-03-23 Ketocytonyx Inc Triglycerides, fatty acids, alcohols as cns modulators
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds

Also Published As

Publication number Publication date
DE2425988A1 (en) 1974-12-19
FR2231379A1 (en) 1974-12-27
FR2231379B1 (en) 1977-12-23

Similar Documents

Publication Publication Date Title
Norcross et al. A national survey of clinical psychologists: Affiliations and orientations.
KR840000229A (en) Method for preparing oral dosage form of dipyridamole
ES2132091T3 (en) Flexible container for medicines with multiple compartments.
DK338580A (en) Procedure for the preparation of 4-benzyl and 4-benzoyl-substituted imidazole derivatives or pharmaceutical acceptable acid addition salts.
AU533491B2 (en) Bandage for administering drugs to the skin
AU6253886A (en) Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
DE3070407D1 (en) System for demand-based administration of insulin
ES2052495T3 (en) Fluid therapy with l-lactate and / or pyruvate anions.
DK108388A (en) Piperazinylalkyllytherocyclic compounds and pharmaceutical preparations containing these
EP0504881A3 (en) Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
NZ217821A (en) Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
JPS61236749A (en) Manufacture of carboxylic acid alkyl ester, particularly fatty acid alkyl ester and use for diesel fuel
AT110956T (en) Applicable film to the oral slime and preparation of medicinal products based on this film.
CA1017871A (en) Instruction fetch apparatus with combined look-ahead and look-behind capability
DE3372845D1 (en) Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof
DK499185D0 (en) Pharmaceutical preparation with a content of ibuprofen and procedure for preparing it
AU591705B2 (en) Emulsion compositions for the parenteral and/or oral administration of sparingly water soluble ionizable hydrophobic drugs
DE68907858D1 (en) Medicinal preparations for transdermal administration of active substances.
CA2086847A1 (en) Stable, liquid products containing fat-soluble substances
ES2007607A6 (en) An insulin preparation for non-parenteral administration.
DK653688D0 (en) Stabilized pharmaceutical active compounds, procedures for their preparation and stable pharmaceutical preparations
AT102629T (en) Peptide derivatives of the blood plate aggregation inhibitor.
NL930045I1 (en) 7-Acylamino-3-vinyl cephalosporanic acid derivatives, methods of preparation thereof, pharmaceutical preparations containing them, their starting compounds and the preparation thereof
PT82460B (en) Method for preparing new imidazoquinolin derivatives with antitrombogenic cardiotonic activity and pharmaceutical compositions that contain them
DK359289D0 (en) 4-oxoquinolin-3-carboxylic acid derivatives and procedures for the preparation of them and their use

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee